FKB - Trademark Details
Status: 640 - Non-Final Action Counted - Not Mailed
Image for trademark with serial number 79313063
Serial Number
79313063
Word Mark
FKB
Status
640 - Non-Final Action Counted - Not Mailed
Status Date
2022-01-28
Filing Date
2021-05-10
Mark Drawing
4000 - Standard character mark Typeset
Law Office Assigned Location Code
L70
Employee Name
KAPLAN, VALERIE ELIZAB
Statements
Goods and Services
Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; pharmaceutical preparations for use in connection with humans for the prevention of mental disorders; pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; pharmaceutical preparations for use in connection with humans for the treatment of deformations; pharmaceutical preparations for use in connection with humans for the prevention of deformations; pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; prescribed pharmaceutical preparations for the treatment of infectious diseases; prescribed pharmaceutical preparations for the prevention of infectious diseases; prescribed pharmaceutical preparations for the treatment of parasitic diseases; prescribed pharmaceutical preparations for the prevention of parasitic diseases; prescribed pharmaceutical preparations for the treatment of neoplasms; prescribed pharmaceutical preparations for the prevention of neoplasms; prescribed pharmaceutical preparations for the treatment of diseases of the blood; prescribed pharmaceutical preparations for the prevention of diseases of the blood prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; prescribed pharmaceutical preparations for the treatment of endocrine diseases; prescribed pharmaceutical preparations for the prevention of endocrine diseases; prescribed pharmaceutical preparations for the treatment of nutritional diseases; prescribed pharmaceutical preparations for the prevention of nutritional diseases; prescribed pharmaceutical preparations for the treatment of metabolic diseases; prescribed pharmaceutical preparations for the prevention of metabolic diseases; prescribed pharmaceutical preparations for the treatment of mental disorders; prescribed pharmaceutical preparations for the prevention of mental disorders; prescribed pharmaceutical preparations for the treatment of behavioural disorders; prescribed pharmaceutical preparations for the prevention of behavioural disorders; prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; prescribed pharmaceutical preparations for the treatment of diseases of the eye; prescribed pharmaceutical preparations for the prevention of diseases of the eye; prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; prescribed pharmaceutical preparations for the treatment of diseases of the ear; prescribed pharmaceutical preparations for the prevention of diseases of the ear; prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; prescribed pharmaceutical preparations for the treatment of diseases of the skin; prescribed pharmaceutical preparations for the prevention of diseases of the skin; prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; prescribed pharmaceutical preparations for the treatment of congenital malformations; prescribed pharmaceutical preparations for the prevention of congenital malformations; prescribed pharmaceutical preparations for the treatment of deformations; prescribed pharmaceutical preparations for the prevention of deformations; prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; biological pharmaceutical preparations for the treatment of infectious diseases; biological pharmaceutical preparations for the prevention of infectious diseases; biological pharmaceutical preparations for the treatment of parasitic diseases; biological pharmaceutical preparations for the prevention of parasitic diseases; biological pharmaceutical preparations for the treatment of neoplasms; biological pharmaceutical preparations for the prevention of neoplasms; biological pharmaceutical preparations for the treatment of diseases of the blood; biological pharmaceutical preparations for the prevention of diseases of the blood; biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; biological pharmaceutical preparations for the treatment of endocrine diseases; biological pharmaceutical preparations for the prevention of endocrine diseases; biological pharmaceutical preparations for the treatment of nutritional diseases; biological pharmaceutical preparations for the prevention of nutritional diseases; biological pharmaceutical preparations for the treatment of metabolic diseases; biological pharmaceutical preparations for the prevention of metabolic diseases; biological pharmaceutical preparations for the treatment of mental disorders; biological pharmaceutical preparations for the prevention of mental disorders; biological pharmaceutical preparations for the treatment of behavioural disorders; biological pharmaceutical preparations for the prevention of behavioural disorders; biological pharmaceutical preparations for the treatment of diseases of the nervous system; biological pharmaceutical preparations for the prevention of diseases of the nervous system; biological pharmaceutical preparations for the treatment of diseases of the eye; biological pharmaceutical preparations for the prevention of diseases of the eye; biological pharmaceutical preparations for the treatment of diseases of eye adnexa; biological pharmaceutical preparations for the prevention of diseases of eye adnexa; biological pharmaceutical preparations for the treatment of diseases of the ear; biological pharmaceutical preparations for the prevention of diseases of the ear; biological pharmaceutical preparations for the treatment of diseases of the mastoid process; biological pharmaceutical preparations for the prevention of diseases of the mastoid process; biological pharmaceutical preparations for the treatment of diseases of the circulatory system; biological pharmaceutical preparations for the prevention of diseases of the circulatory system; biological pharmaceutical preparations for the treatment of diseases of the respiratory system; biological pharmaceutical preparations for the prevention of diseases of the respiratory system; biological pharmaceutical preparations for the treatment of diseases of the digestive system; biological pharmaceutical preparations for the prevention of diseases of the digestive system; biological pharmaceutical preparations for the treatment of diseases of the skin; biological pharmaceutical preparations for the prevention of diseases of the skin; biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; biological pharmaceutical preparations for the treatment of diseases of the connective tissue; biological pharmaceutical preparations for the prevention of diseases of the connective tissue; biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; biological pharmaceutical preparations for the treatment of congenital malformations; biological pharmaceutical preparations for the prevention of congenital malformations; biological pharmaceutical preparations for the treatment of deformations; biological pharmaceutical preparations for the prevention of deformations; biological pharmaceutical preparations for the treatment of chromosomal abnormalities; biological pharmaceutical preparations for the prevention of chromosomal abnormalities; bandages for dressings
Goods and Services
Apparatus for drug administration, namely, drug delivery systems, injector, autoinjector; therapeutic inhalers, sold empty; high frequency electromagnetic therapy apparatus; oxygen inhalers for therapeutic purposes; ultraviolet radiator units for therapeutic purposes; defibrillators; pneumothorax apparatus, namely, medical apparatus for diagnosing or treating respiratory conditions; heart pacemakers; mercury arc lamp units for therapeutic purposes; infrared radiator units for therapeutic purposes; puncture apparatus for therapeutic purposes, namely, medical devices for closing wounds; lavage apparatus for therapeutic purposes, namely, apparatus for washing out body cavities; carbon arc lamp units for therapeutic purposes; injection syringes, syringe barrels; injection needles; infusion apparatus for therapeutic purposes, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over rime; ultrasonic therapy machines and apparatus; short wave therapy machines and apparatus; therapeutic bath apparatus and instruments, namely, appliances for washing body cavities; massage apparatus for medical purposes; low frequency electric therapy apparatus; static electric therapy apparatus; dialyzers, namely, blood component separation apparatus for medical purposes; acupuncture needles; sprayers for medical purposes, namely, drug delivery sprayers sold empty; suture apparatus for medical purposes, namely, suture needles and suture materials; radioisotope therapy apparatus and instruments; incubators for babies; blood transfusion apparatus; containers and trays specially designed for transporting and holding pharmaceuticals; injection device for pharmaceuticals; injection instruments without needles; injection instruments with needles
Goods and Services
Providing information concerning commercial sales in the field of pharmaceuticals
Goods and Services
Custom manufacture of pharmaceuticals
Goods and Services
Pharmaceutical research; pharmaceutical development
Goods and Services
Pharmaceutical information services provided via the Internet, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information
Pseudo Mark
FUJIFILM KYOWA KIRIN BIOLOGICS
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
010
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
035
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-06-25
Primary Code
044
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
MIZUNO Katsufumi
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1190741
International Registration Date
2013-11-15
International Publication Date
2021-06-10
International Renewal Date
2023-11-15
Auto Protection Date
2022-12-10
International Status
001 - Request for extension of protection established
International Status Date
2021-06-11
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2021-06-11SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
2021-06-21LIMITATION FROM ORIGINAL APPLICATION ENTERED
2021-06-25NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-06-29APPLICATION FILING RECEIPT MAILED
2022-01-14ASSIGNED TO EXAMINER
2022-01-28NON-FINAL ACTION WRITTEN
2022-01-29NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW